Home Depot Sales Could Soften Due to Tariffs — Negative

HD   PYMNTS — May 19, 2025

One of Home Depot's critical sales metrics is expected to slow when it reports earnings. That's according to a report Monday (May 19) from Bloomberg News, citing a survey of analysts who say the home improvement retailer's comparable sales are projected to soften.

image for news Home Depot Sales Could Soften Due to Tariffs

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Rocket Companies, Inc. ("Rocket Companies" or the "Company") (NYSE: RKT) of a class action securities lawsuit.

image for news Investors who lost money on Rocket Companies, Inc.(RKT) should contact Levi & Korsinsky about pending Class Action - RKT

NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=149244&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Urges Iovance (IOVA) Shareholders to Act Before Lead Plaintiff Deadline July 14, 2025

NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your Perpetua Resources Corp. (NASDAQ:PPTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/perpetua-resources-corp-lawsuit-submission-form?prid=149242&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq.

image for news Securities Lawsuit Alert: Perpetua Resources Corp. (PPTA) - Contact Levi & Korsinsky Before May 20, 2025

NEW YORK, NY / ACCESS Newswire / May 19, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cable One, Inc. ("Cable One, Inc.") (NYSE:CABO) concerning possible violations of federal securities laws. On May 2, 2025, Cable One missed earnings expectations by nearly $8 and suspended its dividend.

image for news Did Cable One, Inc. (CABO) Mislead Investors? Levi & Korsinsky Investigates

NEW YORK, NY / ACCESS Newswire / May 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Landstar System, Inc. ("Landstar" or the "Company") (NASDAQ:LSTR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Landstar System, Inc. - LSTR

NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of SelectQuote, Inc. ("SelectQuote" or the "Company") (NYSE:SLQT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SelectQuote, Inc. - SLQT

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sana Biotechnology, Inc. (NASDAQ: SANA) between March 17, 2023 and November 4, 2024, inclusive (the “Class Period”), of the important May 20, 2025 lead plaintiff deadline.

image for news SANA DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important May 20 Deadline in Securities Class Action – SANA

American Woodmark is trading at a 10-year low valuation in April-May, screaming deep value for contrarian investors. New 2025 tariffs on imported cabinets could give AMWD a significant competitive edge, especially if U.S. trade policies soon tighten under the Trump administration. Any rebound in housing or remodeling demand, combined with tariff protection, could drive a sharp stock price recovery into 2026.

image for news The Bottom Fishing Club: American Woodmark Could Be Major Tariff Beneficiary

Novo Nordisk is banking on fresh leadership to help it reclaim the crown in the booming weight loss drug market. The Danish drugmaker last week abruptly announced that longtime CEO Lars Fruergaard Jorgensen is stepping down, as its obesity injection Wegovy loses ground to Eli Lilly's rival treatment, Zepbound.

image for news Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly

Target Hospitality (TH) Reports Q1 Loss, Tops Revenue Estimates — Negative

TH   Zacks Investment Research — May 19, 2025

Target Hospitality (TH) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to earnings of $0.20 per share a year ago.

image for news Target Hospitality (TH) Reports Q1 Loss, Tops Revenue Estimates

Why Nvidia (NVDA) Could Beat Earnings Estimates Again — Positive

NVDA   Zacks Investment Research — May 19, 2025

Nvidia (NVDA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Why Nvidia (NVDA) Could Beat Earnings Estimates Again

Will MongoDB (MDB) Beat Estimates Again in Its Next Earnings Report? — Positive

MDB   Zacks Investment Research — May 19, 2025

MongoDB (MDB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will MongoDB (MDB) Beat Estimates Again in Its Next Earnings Report?

Why Burlington Stores (BURL) is Poised to Beat Earnings Estimates Again — Positive

BURL   Zacks Investment Research — May 19, 2025

Burlington Stores (BURL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Why Burlington Stores (BURL) is Poised to Beat Earnings Estimates Again

Why Build-A-Bear (BBW) is Poised to Beat Earnings Estimates Again — Positive

BBW   Zacks Investment Research — May 19, 2025

Build-A-Bear (BBW) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Why Build-A-Bear (BBW) is Poised to Beat Earnings Estimates Again

Why Seanergy Maritime Holdings (SHIP) is Poised to Beat Earnings Estimates Again — Positive

SHIP   Zacks Investment Research — May 19, 2025

Seanergy Maritime Holdings (SHIP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Why Seanergy Maritime Holdings (SHIP) is Poised to Beat Earnings Estimates Again

DALLAS , May 19, 2025 /PRNewswire/ -- Texas Instruments Incorporated (TI) (Nasdaq: TXN) Senior Vice President and Chief Financial Officer Rafael Lizardi will speak at the Bank of America 2025 Global Technology Conference in San Francisco on Wednesday, June 4, at 11:20 a.m. Pacific time.

image for news TI Chief Financial Officer Rafael Lizardi to speak at Bank of America investor conference

ICL Group Ltd (ICL) Q1 2025 Earnings Call Transcript — Neutral

ICL   Seeking Alpha — May 19, 2025

ICL Group Ltd (NYSE:ICL ) Q1 2025 Earnings Conference Call May 19, 2025 4:00 AM ET Company Participants Peggy Reilly Tharp - Vice President, Global Investor Relations Elad Aharonson - President and Chief Executive Officer Aviram Lahav - Chief Financial Officer Conference Call Participants Rahi Parikh - Barclays Bank Operator Good morning, ladies and gentlemen, and welcome to the ICL First Quarter 2025 Earnings Call. At this time, all lines are in listen-only mode.

image for news ICL Group Ltd (ICL) Q1 2025 Earnings Call Transcript

Here's Why Mineralys Therapeutics, Inc. (MLYS) is a Great Momentum Stock to Buy — Positive

MLYS   Zacks Investment Research — May 19, 2025

Does Mineralys Therapeutics, Inc. (MLYS) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Here's Why Mineralys Therapeutics, Inc. (MLYS) is a Great Momentum Stock to Buy

All You Need to Know About Edgewise Therapeutics (EWTX) Rating Upgrade to Buy — Positive

EWTX   Zacks Investment Research — May 19, 2025

Edgewise Therapeutics (EWTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news All You Need to Know About Edgewise Therapeutics (EWTX) Rating Upgrade to Buy